- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 4, 2025 | 13.72M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 13.72M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 13.72M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 13.72M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 13.72M sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $5.22M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $5.76M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $154.17M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $3.55M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $23.09M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $17.51M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $5.85M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $22.43M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $34.6M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $56.21M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $65.07M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $68.42M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $71.09M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $73.46M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $173.83M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $160.72M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $179.67M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $216.93M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.12 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.72 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.11 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.48 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.12 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.72 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.11 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.48 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $478K |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $1.97M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $525K |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $1.79M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$5.05M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$3.74M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$133K |
| Net Income | Q3 2025 · Mar 31, 2025 | $1.45M |
| Net Income | Q3 2025 · Sep 30, 2024 | $357K |
| Net Income | Q3 2025 · Sep 30, 2024 | $698K |
| Net Income | Q3 2025 · Jun 30, 2024 | $18K |
| Net Income | Q3 2025 · Mar 31, 2024 | $323K |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$2.45M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $3.8M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $2.82M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $7.65M |
| Revenue | Q3 2025 · Sep 30, 2025 | $6.85M |
| Revenue | Q3 2025 · Sep 30, 2025 | $21.72M |
| Revenue | Q3 2025 · Sep 30, 2024 | $8.11M |
| Revenue | Q3 2025 · Sep 30, 2024 | $25.49M |